Provided by Tiger Fintech (Singapore) Pte. Ltd.

Krystal Biotech Inc.

130.01
-0.0150-0.01%
Volume:19.32K
Turnover:2.50M
Market Cap:3.76B
PE:31.29
High:131.02
Open:130.86
Low:127.99
Close:130.02
Loading ...

Krystal Biotech Inc. Conducted Annual Meeting of Stockholders

Reuters
·
20 May

Krystal Biotech Is Maintained at Neutral by Citigroup

Dow Jones
·
17 May

Krystal Biotech price target lowered to $155 from $215 at Citi

TIPRANKS
·
16 May

Krystal Biotech (KRYS) Receives a Buy from Evercore ISI

TIPRANKS
·
13 May

Evercore ISI Keeps Their Buy Rating on Krystal Biotech (KRYS)

TIPRANKS
·
08 May

Krystal Biotech Is Maintained at Buy by Chardan Capital

Dow Jones
·
07 May

Krystal Biotech Price Target Maintained With a $240.00/Share by HC Wainwright & Co.

Dow Jones
·
07 May

Krystal Biotech Shares Slip After 1Q Miss

Dow Jones
·
07 May

Stock Track | Krystal Biotech Plummets 14.64% as Q1 Results Fall Short of Expectations

Stock Track
·
06 May

Krystal Biotech Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

BUZZ-Krystal Biotech falls on Q1 results miss

Reuters
·
06 May

Krystal Biotech Shares Extend Losses, Last Down 10.7% Premarket

THOMSON REUTERS
·
06 May

Stock Track | Krystal Biotech Plunges 13.73% Pre-Market on Q1 Earnings Miss and Disappointing Sales

Stock Track
·
06 May

Krystal Biotech's Q1 Earnings, Revenue Rise

MT Newswires Live
·
06 May

Krystal Biotech Shares Down 6.9% Premarket After Q1 Results

THOMSON REUTERS
·
06 May

Krystal Biotech Q1 EPS $1.20 Misses $1.32 Estimate, Sales $88.18M Miss $96.24M Estimate

Benzinga
·
06 May

BRIEF-Krystal Biotech Q1 Net Income USD 35.733 Million

Reuters
·
06 May

Krystal Biotech Inc: Q1 EPS $1.20

THOMSON REUTERS
·
06 May

Press Release: Krystal Biotech Announces First Quarter 2025 Financial and Operating Results

Dow Jones
·
06 May

Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline

Zacks
·
01 May